Cargando…
Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
Glucocorticoids (GCs) are the most commonly used drugs for treatment of autoimmune and inflammatory diseases. Their efficacy is due to their ability to bind cytoplasmic receptors (glucocorticoid receptors, GR) and other cytoplasmic proteins, thus regulating gene expression. Although GCs are potent l...
Autores principales: | Bereshchenko, Oxana, Migliorati, Graziella, Bruscoli, Stefano, Riccardi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445858/ https://www.ncbi.nlm.nih.gov/pubmed/30971930 http://dx.doi.org/10.3389/fphar.2019.00308 |
Ejemplares similares
-
Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)
por: Paglialunga, Musetta, et al.
Publicado: (2023) -
Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice
por: Bruscoli, Stefano, et al.
Publicado: (2018) -
Role of histamine H(4) receptor in the anti-inflammatory pathway of glucocorticoid-induced leucin zipper (GILZ) in a model of lung fibrosis
por: Sgambellone, Silvia, et al.
Publicado: (2023) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021) -
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment
por: Flamini, Sara, et al.
Publicado: (2021)